Stefania Elena Navone

9PUBLICATIONS
18CO-AUTHORS
Molecular targetsNaturopathyGenomicsGene and molecular therapyPredictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (9)

|Aug 13, 2026
Reduced-Dose Regorafenib for Recurrent Glioblastoma: A Safety and Outcome Analysis.

|May 27, 2026
Correction: Navone et al. Role of Luteolin as Potential New Therapeutic Option for Patients with Glioblastoma Through Regulation of Sphingolipid Rheostat. Int. J. Mol. Sci. 2024, 25, 130.

|Nov 13, 2025
Modeling Glioblastoma with Brain Organoids: New Frontiers in Oncology and Space Research.

Laura Begani, Luigi Gianmaria Remore, Stefania Ragosta

|Jan 11, 2024
Role of Luteolin as Potential New Therapeutic Option for Patients with Glioblastoma through Regulation of Sphingolipid Rheostat.

Stefania Elena Navone, Laura Guarnaccia, Massimiliano D Rizzaro

|Jul 27, 2022
A Targeted Next-Generation Sequencing Panel to Genotype Gliomas.

Maria Guarnaccia, Laura Guarnaccia, Valentina La Cognata

|Mar 25, 2022
Effects of Metformin as Add-On Therapy against Glioblastoma: An Old Medicine for Novel Oncology Therapeutics.

Laura Guarnaccia, Stefania E Navone, Matteo M Masseroli

Pageof 2

Frequent Collaborators

4 joint publications

Emanuele Garzia

4 joint publications

Laura Guarnaccia

3 joint publications

Giovanni Marfia

2 joint publications

Melissa Balsamo